Caricamento…
Tutte le aziende qui passate per gli stessi cinque controlli su crescita e generazione di cassa. Descrive il settore così come rendiconta oggi, non quale di queste comprare.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | 138,7B USD | 547,02 USD | 35,22 | 13B USD | 30,7% |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | 101,3B USD | 959,45 USD | 21,18 | 16,9B USD | 28,5% |
| MRNA | Moderna, Inc. | C- | 100,6B USD | 248,70 USD | — | 2,5B USD | -110,5% |
| ARGX | ARGENX SE | non valutata | 60,5B USD | 977,29 USD | 49,94 | — | — |
| ONC | BEONE MEDICINES LTD. | A+ | 48B USD | 420,06 USD | 53,85 | 6,6B USD | 13,9% |
| RPRX | Royalty Pharma plc | C+ | 40,1B USD | 69,97 USD | 45,73 | 2,6B USD | 25,7% |
| RVMD | Revolution Medicines, Inc. | F | 39,1B USD | 180,66 USD | — | 0,00 USD | — |
| ROIV | ROIVANT SCIENCES LTD. | B- | 30,3B USD | 41,85 USD | — | 41,1M USD | -838,2% |
| INSM | INSMED INC | C- | 26,5B USD | 120,64 USD | — | 1,5B USD | -39,9% |
| INCY | INCYTE CORPORATION | C | 24,9B USD | 122,23 USD | 65,01 | 6B USD | 6,7% |
| BNTX | BioNTech SE | F | 22B USD | 87,64 USD | — | 2,7B USD | -60,9% |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | B+ | 21,4B USD | 159,80 USD | 68,58 | 3,7B USD | 71,3% |
| NCNA | NUCANA PLC | non valutata | 19,5B USD | 0,94 USD | — | — | — |
| EXEL | EXELIXIS, INC. | A+ | 17,3B USD | 70,71 USD | 21,17 | 2,5B USD | 35,5% |
| ASND | Ascendis Pharma A/S | D | 16,1B USD | 259,10 USD | — | 1,2B USD | -21,8% |
| JAZZ | Jazz Pharmaceuticals plc | A | 15,9B USD | 248,18 USD | 80,84 | 4,7B USD | 4,4% |
| BBIO | BridgeBio Pharma, Inc. | B | 15,5B USD | 79,53 USD | — | 945,5M USD | -60,7% |
| SMMT | Summit Therapeutics Inc. | non valutata | 13,3B USD | 16,63 USD | — | — | — |
| AKTX | Akari Therapeutics Plc | non valutata | 11,9B USD | 7,62 USD | — | — | — |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | 11,6B USD | 101,69 USD | 25,36 | 1,8B USD | 26,9% |
| KYMR | KYMERA THERAPEUTICS, INC. | F- | 11,5B USD | 134,90 USD | — | 102,2M USD | -341,8% |
| TECH | BIO-TECHNE Corp | A+ | 11,4B USD | 72,78 USD | 66,77 | 1,2B USD | 14,0% |
| BMRN | BioMarin Pharmaceutical Inc | B | 11,3B USD | 58,32 USD | — | 3,7B USD | -0,5% |
| PCVX | VAXCYTE, INC. | non valutata | 10,9B USD | 68,62 USD | — | — | — |
| SYRE | SPYRE THERAPEUTICS, INC. | D | 10,1B USD | 106,77 USD | — | 0,00 USD | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | B- | 10,1B USD | 432,64 USD | — | 1,4B USD | -10,9% |
| TGTX | TG THERAPEUTICS, INC. | A+ | 9,9B USD | 65,75 USD | 98,13 | 897,8M USD | 11,8% |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | 9,7B USD | 346,46 USD | — | 0,00 USD | — |
| KRYS | Krystal Biotech, Inc. | A+ | 9,2B USD | 308,82 USD | 41,90 | 470M USD | 47,9% |
| PTGX | PROTAGONIST THERAPEUTICS, INC. | A+ | 8,8B USD | 134,76 USD | 28,61 | 551,7M USD | 62,0% |
| CORT | CORCEPT THERAPEUTICS INC | A+ | 8,2B USD | 74,52 USD | 58,68 | 963,6M USD | 16,8% |
| CYTK | CYTOKINETICS, INCORPORATED | D | 8,2B USD | 58,52 USD | — | 113,3M USD | -686,6% |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | 7,8B USD | 149,20 USD | — | 865,3M USD | -18,2% |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | 7,8B USD | 112,18 USD | — | 280,7M USD | -69,0% |
| TWST | Twist Bioscience Corporation | C- | 7,7B USD | 122,71 USD | — | 459,4M USD | -28,3% |
| IMVT | Immunovant, Inc. | non valutata | 7,7B USD | 37,04 USD | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | non valutata | 7,3B USD | 107,10 USD | — | — | — |
| ABVX | Abivax S.A. | non valutata | 7,2B USD | 91,37 USD | — | — | — |
| IBRX | IMMUNITYBIO, INC. | C | 7,1B USD | 6,67 USD | — | 182,6M USD | -607,8% |
| CAI | CARIS LIFE SCIENCES, INC. | A | 7B USD | 24,50 USD | 14,76 | 1B USD | 9,2% |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | F- | 7B USD | 49,36 USD | — | 450,8M USD | -160,6% |
| KOD | Kodiak Sciences Inc. | non valutata | 6,9B USD | 109,23 USD | — | — | — |
| MANE | Veradermics, Inc | non valutata | 6,6B USD | 156,30 USD | — | — | — |
| CGON | CG Oncology, Inc. | F- | 6,5B USD | 72,66 USD | — | 6,2M USD | -3851,1% |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | C | 6,3B USD | 317,16 USD | 137,90 | 253,8M USD | 20,3% |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | 6,2B USD | 94,64 USD | — | 670,8M USD | -134,8% |
| BLTE | Belite Bio, Inc | non valutata | 6,1B USD | 155,94 USD | — | — | — |
| ERAS | ERASCA, INC. | non valutata | 5,9B USD | 16,80 USD | — | — | — |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F- | 5,7B USD | 46,54 USD | — | 570K USD | -72.563,2% |
| PTCT | PTC Therapeutics, Inc. | D | 5,4B USD | 64,87 USD | — | 1,2B USD | -9,2% |
| EWTX | Edgewise Therapeutics, Inc. | non valutata | 5,2B USD | 47,58 USD | 5,82 | — | — |
| COGT | Cogent Biosciences, Inc. | non valutata | 5,1B USD | 29,39 USD | — | — | — |
| DNTH | Dianthus Therapeutics, Inc. | F- | 5B USD | 89,24 USD | — | 2M USD | -9927,5% |
| TVTX | TRAVERE THERAPEUTICS, INC. | F- | 5B USD | 52,06 USD | — | 651M USD | -18,7% |
| DFTX | Definium Therapeutics, Inc. | non valutata | 4,7B USD | 34,46 USD | — | — | — |
| IONS | IONIS PHARMACEUTICALS, INC. | F- | 4,7B USD | 28,31 USD | — | 960,1M USD | -56,9% |
| GPCR | Structure Therapeutics Inc. | non valutata | 4,5B USD | 20,98 USD | — | — | — |
| CRSP | CRISPR THERAPEUTICS AG | F- | 4,5B USD | 45,89 USD | — | 25,2M USD | -1812,1% |
| TNGX | TANGO THERAPEUTICS, INC. | F | 4,4B USD | 25,71 USD | — | 0,00 USD | — |
| RLAY | RELAY THERAPEUTICS, INC. | D- | 4,4B USD | 19,71 USD | — | 10,4M USD | -2837,0% |
| ZLAB | ZAI LAB LIMITED | F- | 4,3B USD | 26,43 USD | — | 441,7M USD | -44,9% |
| XENE | Xenon Pharmaceuticals Inc. | F | 4,1B USD | 42,09 USD | — | 0,00 USD | — |
| IRON | Disc Medicine, Inc. | non valutata | 4B USD | 87,11 USD | — | — | — |
| ABCL | AbCellera Biologics Inc. | C- | 3,9B USD | 11,94 USD | — | 67,9M USD | -218,5% |
| TARS | TARSUS PHARMACEUTICALS, INC. | B- | 3,8B USD | 76,71 USD | — | 682,2M USD | -102,9% |
| ELVN | ENLIVEN THERAPEUTICS, INC. | non valutata | 3,8B USD | 51,17 USD | — | — | — |
| DBVT | DBV TECHNOLOGIES S.A. | F- | 3,7B USD | 11,91 USD | — | 3,8M USD | -5405,3% |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | 3,7B USD | 8,08 USD | — | 379M USD | -58,2% |
| PBLS | Parabilis Medicines, Inc. | non valutata | 3,7B USD | 29,64 USD | — | — | — |
| VKTX | VIKING THERAPEUTICS, INC. | F | 3,6B USD | 28,43 USD | — | 0,00 USD | — |
| LEGN | Legend Biotech Corp | C- | 3,6B USD | 19,54 USD | — | 1,1B USD | -22,0% |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | B | 3,6B USD | 28,36 USD | 135,05 | 508,7M USD | 5,9% |
| VRDN | Viridian Therapeutics, Inc./DE | F- | 3,5B USD | 31,24 USD | — | 26,3M USD | -1724,1% |
| GMAB | Genmab A/S | B+ | 3,4B USD | 53,87 USD | 3,50 | 3,9B USD | 21,0% |
| DYN | Dyne Therapeutics, Inc. | non valutata | 3,4B USD | 17,98 USD | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D | 3,3B USD | 9,73 USD | — | 890,8M USD | 3,8% |
| ACAD | ACADIA PHARMACEUTICALS INC. | B+ | 3,2B USD | 18,35 USD | 8,66 | 1,2B USD | 30,1% |
| DNLI | Denali Therapeutics Inc. | F | 3,2B USD | 19,73 USD | — | 0,00 USD | — |
| IDYA | IDEAYA Biosciences, Inc. | F- | 3,2B USD | 32,69 USD | — | 36,5M USD | -1149,6% |
| CELC | CELCUITY INC. | non valutata | 3,2B USD | 64,31 USD | — | — | — |
| VCEL | VERICEL CORPORATION | A | 3B USD | 59,40 USD | 92,81 | 324,2M USD | 10,3% |
| XNCR | Xencor, Inc | D- | 3B USD | 39,99 USD | — | 200,5M USD | -58,8% |
| ADMA | ADMA BIOLOGICS, INC. | B+ | 2,9B USD | 13,19 USD | 17,13 | 519,2M USD | 35,1% |
| MBX | MBX Biosciences, Inc. | non valutata | 2,9B USD | 57,49 USD | — | — | — |
| RCUS | Arcus Biosciences, Inc. | F- | 2,7B USD | 18,80 USD | — | 100M USD | -453,0% |
| BEAM | Beam Therapeutics Inc. | F- | 2,7B USD | 25,79 USD | — | 146,6M USD | -73,9% |
| NAMS | NewAmsterdam Pharma Company N.V. | D- | 2,5B USD | 20,75 USD | — | 25,9M USD | -789,9% |
| PVLA | Palvella Therapeutics, Inc. | non valutata | 2,4B USD | 163,83 USD | — | — | — |
| CLDX | Celldex Therapeutics, Inc. | F- | 2,4B USD | 30,14 USD | — | 158K USD | -195.608,9% |
| SEPN | Septerna, Inc. | F- | 2,3B USD | 48,54 USD | — | 96,3M USD | -61,3% |
| BHVN | Biohaven Ltd. | non valutata | 2,3B USD | 15,20 USD | — | — | — |
| IMNM | Immunome Inc. | F | 2,3B USD | 19,07 USD | — | 0,00 USD | — |
| VIR | Vir Biotechnology, Inc. | C- | 2,2B USD | 13,12 USD | — | 302,8M USD | -61,0% |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | 2,2B USD | 3,59 USD | — | 68,2M USD | -697,1% |
| PHVS | Pharvaris N.V. | non valutata | 2,2B USD | 34,12 USD | — | — | — |
| VERA | Vera Therapeutics, Inc. | non valutata | 2,2B USD | 30,44 USD | — | — | — |
| LKFT | GALAPAGOS NV | D | 2,2B USD | 33,38 USD | 6,14 | 1,2B USD | 28,9% |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | 2,2B USD | 16,21 USD | 7,08 | 321,7M USD | 97,7% |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | non valutata | 2,1B USD | 50,53 USD | — | — | — |
| TRVI | TREVI THERAPEUTICS, INC. | non valutata | 2,1B USD | 14,82 USD | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | non valutata | 2,1B USD | 21,76 USD | — | — | — |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | B+ | 2B USD | 34,23 USD | 11,30 | 989,4M USD | 18,1% |
| MAZE | MAZE THERAPEUTICS, INC. | non valutata | 2B USD | 36,72 USD | — | — | — |
| ZYME | ZYMEWORKS INC. | F+ | 2B USD | 29,03 USD | 55,83 | 266M USD | 16,3% |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | 2B USD | 7,70 USD | — | 213M USD | -30,8% |
| FTRE | Fortrea Holdings Inc. | C | 2B USD | 20,38 USD | — | 2,7B USD | -2,6% |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | 2B USD | 32,83 USD | — | 140,8M USD | -264,8% |
| ZBIO | Zenas BioPharma, Inc. | F- | 1,9B USD | 28,68 USD | — | 10M USD | -5418,1% |
| BRVE | Braveheart Bio, Inc. | non valutata | 1,9B USD | 20,83 USD | — | — | — |
| KLRA | Kailera Therapeutics, Inc. | non valutata | 1,9B USD | 14,38 USD | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | non valutata | 1,8B USD | 39,23 USD | — | — | — |
| STOK | Stoke Therapeutics, Inc. | F- | 1,8B USD | 27,72 USD | — | 28,2M USD | -862,1% |
| SRPT | SAREPTA THERAPEUTICS, INC. | C | 1,8B USD | 16,68 USD | — | 2B USD | -5,9% |
| NRIX | NURIX THERAPEUTICS, INC. | A+ | 1,8B USD | 16,33 USD | 7,10 | 701,9M USD | 42,0% |
| MESO | MESOBLAST LIMITED | C- | 1,8B USD | 13,66 USD | — | 65,4M USD | -144,3% |
| GENB | Generate Biomedicines, Inc. | non valutata | 1,7B USD | 13,49 USD | — | — | — |
| ABSI | ABSCI CORP | F- | 1,7B USD | 10,08 USD | — | 1,6M USD | -8050,7% |
| QURE | uniQure N.V. | F- | 1,7B USD | 24,61 USD | — | 20,2M USD | -1154,8% |
| SLS | SELLAS Life Sciences Group, Inc. | non valutata | 1,7B USD | 8,43 USD | — | — | — |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | 1,7B USD | 16,70 USD | — | 730M USD | -71,8% |
| PGEN | PRECIGEN, INC. | C | 1,7B USD | 4,71 USD | 47,10 | 156,9M USD | 15,6% |
| NVAX | NOVAVAX, INC. | F | 1,6B USD | 9,97 USD | — | 411,6M USD | -18,6% |
| IMCR | Immunocore Holdings plc | F- | 1,6B USD | 31,64 USD | — | 429,3M USD | -7,5% |
| NTLA | INTELLIA THERAPEUTICS, INC. | D- | 1,6B USD | 11,41 USD | — | 52,9M USD | -805,7% |
| RAPP | Rapport Therapeutics, Inc. | non valutata | 1,6B USD | 27,00 USD | — | — | — |
| NBTX | Nanobiotix S.A. | C- | 1,6B USD | 33,00 USD | — | 36,4M USD | -73,5% |
| NUVB | Nuvation Bio Inc. | C- | 1,5B USD | 4,28 USD | — | 201,7M USD | -67,4% |
| OCUL | OCULAR THERAPEUTIX, INC | F- | 1,5B USD | 6,64 USD | — | 50,4M USD | -648,6% |
| ANAB | ANAPTYSBIO, INC. | C+ | 1,5B USD | 48,73 USD | 8,49 | 237,6M USD | 77,6% |
| TYRA | TYRA BIOSCIENCES, INC. | non valutata | 1,4B USD | 20,93 USD | — | — | — |
| LBRX | LB Pharmaceuticals Inc | non valutata | 1,4B USD | 44,65 USD | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | non valutata | 1,4B USD | 23,24 USD | — | — | — |
| MLYS | MINERALYS THERAPEUTICS, INC. | non valutata | 1,4B USD | 16,18 USD | — | — | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | D- | 1,4B USD | 15,19 USD | — | 96,6M USD | -193,4% |
| AVLN | Avalyn Pharma Inc. | non valutata | 1,4B USD | 31,57 USD | — | — | — |
| TSHA | Taysha Gene Therapies, Inc. | F- | 1,4B USD | 4,27 USD | — | 5,5M USD | -2844,6% |
| MNKD | MannKind Corporation | D | 1,3B USD | 4,18 USD | — | 413,4M USD | -18,1% |
| INVA | INNOVIVA, INC. | C+ | 1,3B USD | 18,86 USD | 9,43 | 438,3M USD | 44,1% |
| INBX | INHIBRX BIOSCIENCES, INC. | F- | 1,3B USD | 90,63 USD | — | 1,3M USD | -10.629,3% |
| OMER | OMEROS CORP | non valutata | 1,3B USD | 18,14 USD | 10,55 | — | — |
| NKTR | Nektar Therapeutics | F- | 1,3B USD | 38,43 USD | — | 52,2M USD | -339,7% |
| URGN | UroGen Pharma Ltd. | C | 1,3B USD | 26,07 USD | — | 250,3M USD | -26,3% |
| ANRO | Alto Neuroscience, Inc. | non valutata | 1,2B USD | 31,15 USD | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | non valutata | 1,2B USD | 14,05 USD | — | — | — |
| VOR | Vor Biopharma Inc. | non valutata | 1,2B USD | 20,10 USD | 0,07 | — | — |
| GHRS | GH Research PLC | non valutata | 1,2B USD | 19,22 USD | — | — | — |
| SGP | SpyGlass Pharma, Inc. | non valutata | 1,2B USD | 34,90 USD | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | non valutata | 1,1B USD | 13,50 USD | — | — | — |
| VSTM | Verastem, Inc. | F- | 1,1B USD | 9,09 USD | — | 100,3M USD | -178,4% |
| SPTX | Seaport Therapeutics, Inc. | non valutata | 1,1B USD | 21,26 USD | — | — | — |
| SVRA | Savara Inc. | non valutata | 1,1B USD | 4,99 USD | — | — | — |
| JBIO | Jade Biosciences, Inc. | non valutata | 1,1B USD | 16,56 USD | — | — | — |
| ODTX | Odyssey Therapeutics, Inc. | non valutata | 1B USD | 20,94 USD | — | — | — |
| CRVS | Corvus Pharmaceuticals, Inc. | non valutata | 968,8M USD | 11,49 USD | — | — | — |
| AKTS | Aktis Oncology, Inc. | non valutata | 950,8M USD | 17,04 USD | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | 936,9M USD | 12,98 USD | — | 92M USD | -217,8% |
| SLN | Silence Therapeutics plc | D- | 934,1M USD | 19,77 USD | — | 615K USD | -8361,1% |
| ORIC | ORIC PHARMACEUTICALS, INC. | non valutata | 930,8M USD | 8,98 USD | — | — | — |
| MGTX | MeiraGTx Holdings plc | A | 930,7M USD | 9,69 USD | 13,65 | 397,5M USD | 19,9% |
| PHAR | Pharming Group N.V. | A | 929,4M USD | 13,25 USD | 331,13 | 376,1M USD | 0,8% |
| IMTX | Immatics N.V. | non valutata | 898,3M USD | 6,70 USD | — | — | — |
| LTGO | Latigo Biotherapeutics, Inc. | non valutata | 897,7M USD | 13,54 USD | — | — | — |
| GLUE | Monte Rosa Therapeutics, Inc. | F- | 880,1M USD | 10,30 USD | — | 70,3M USD | -186,2% |
| ANNX | ANNEXON, INC. | non valutata | 861,1M USD | 4,19 USD | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | 856,4M USD | 9,59 USD | — | 289,7M USD | -72,3% |
| ALMS | Alumis Inc. | F- | 856,2M USD | 6,62 USD | — | 7,2M USD | -5844,5% |
| SLDB | Solid Biosciences Inc. | non valutata | 849,4M USD | 7,61 USD | — | — | — |
| RIGL | RIGEL PHARMACEUTICALS INC | B+ | 837,7M USD | 44,49 USD | 2,77 | 288,2M USD | 106,6% |
| LXRX | Lexicon Pharmaceuticals, Inc. | D- | 828,1M USD | 1,86 USD | — | 38,5M USD | -161,8% |
| SGMT | Sagimet Biosciences Inc. | non valutata | 814,3M USD | 11,41 USD | — | — | — |
| AURA | AURA BIOSCIENCES, INC. | non valutata | 792M USD | 7,61 USD | — | — | — |
| ARDX | ARDELYX, INC. | C- | 785,5M USD | 3,13 USD | — | 468,2M USD | -11,8% |
| PRME | Prime Medicine, Inc. | D- | 779M USD | 4,30 USD | — | 4,6M USD | -4056,4% |
| IVA | Inventiva S.A. | F | 776,8M USD | 4,02 USD | — | 5M USD | -7899,6% |
| ATTO | Attovia Therapeutics, Inc. | non valutata | 766,8M USD | 16,78 USD | — | — | — |
| JANX | Janux Therapeutics, Inc. | C- | 755,6M USD | 12,35 USD | — | 23,3M USD | -428,7% |
| ACHV | Achieve Life Sciences, Inc. | non valutata | 747,1M USD | 6,79 USD | — | — | — |
| OABI | OMNIAB, INC. | B | 743,9M USD | 5,10 USD | — | 40,2M USD | -108,1% |
| CGEM | CULLINAN THERAPEUTICS, INC. | non valutata | 735,6M USD | 11,33 USD | — | — | — |
| NVCT | NUVECTIS PHARMA, INC. | non valutata | 721,5M USD | 20,98 USD | — | — | — |
| CLYM | Climb Bio, Inc. | non valutata | 719,5M USD | 12,25 USD | — | — | — |
| KURA | Kura Oncology, Inc. | C- | 710,2M USD | 7,73 USD | — | 79,3M USD | -369,3% |
| CADL | CANDEL THERAPEUTICS, INC. | non valutata | 705,1M USD | 9,22 USD | — | — | — |
| ZVRA | Zevra Therapeutics, Inc. | B+ | 704,8M USD | 11,85 USD | 9,95 | 147,8M USD | 52,8% |
| OLMA | OLEMA PHARMACEUTICALS, INC. | non valutata | 703,5M USD | 8,03 USD | — | — | — |
| AVBP | ARRIVENT BIOPHARMA, INC. | non valutata | 699,3M USD | 13,52 USD | — | — | — |
| APMD | Apnimed, Inc. | non valutata | 698,6M USD | 16,78 USD | — | — | — |
| BCAX | BICARA THERAPEUTICS INC. | non valutata | 698,4M USD | 10,52 USD | — | — | — |
| ACRS | Aclaris Therapeutics, Inc. | F- | 689,2M USD | 4,35 USD | — | 6,4M USD | -1244,1% |
| SANA | Sana Biotechnology, Inc. | non valutata | 689,2M USD | 2,30 USD | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | 689M USD | 10,76 USD | — | 0,00 USD | — |
| WVE | WAVE LIFE SCIENCES, INC. | F- | 672,6M USD | 3,41 USD | — | 70,9M USD | -296,9% |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | F- | 664,8M USD | 10,26 USD | — | 130,8M USD | -192,0% |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | 651,8M USD | 11,21 USD | — | 0,00 USD | — |
| GERN | GERON CORP | non valutata | 644,2M USD | 1,00 USD | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | non valutata | 619,2M USD | 8,66 USD | — | — | — |
| ABUS | ARBUTUS BIOPHARMA CORP | D+ | 595,5M USD | 3,89 USD | 3,44 | 181,5M USD | 121,2% |
| CBIO | Crescent Biopharma, Inc. | D- | 573,9M USD | 14,76 USD | — | 15M USD | -727,6% |
| RGNX | REGENXBIO Inc. | F- | 560,1M USD | 8,47 USD | — | 153,9M USD | -113,9% |
| ENTX | ENTERA BIO LTD. | F | 559,9M USD | 3,22 USD | — | 0,00 USD | — |
| DMAC | DIAMEDICA THERAPEUTICS INC. | non valutata | 521,2M USD | 9,66 USD | — | — | — |
| NGNE | Neurogene Inc. | F | 518,8M USD | 25,06 USD | — | 0,00 USD | — |
| STTK | Shattuck Labs, Inc. | F | 512,3M USD | 5,03 USD | — | 0,00 USD | — |
| VALN | Valneva SE | F- | 511,9M USD | 5,90 USD | — | 174,7M USD | -73,7% |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | 510,5M USD | 6,28 USD | — | 274,9M USD | -30,2% |
| AVTX | AVALO THERAPEUTICS, INC. | F- | 492,1M USD | 8,51 USD | — | 59K USD | -150.259,3% |
| GYRE | Gyre Therapeutics, Inc. | F- | 491,8M USD | 4,27 USD | — | 108,1M USD | -33,9% |
| JSPR | Jasper Therapeutics, Inc. | non valutata | 491M USD | 14,76 USD | — | — | — |
| MDXG | MIMEDX GROUP, INC. | F | 483M USD | 3,31 USD | — | 303,7M USD | -6,3% |
| MNPR | Monopar Therapeutics Inc. | F | 482,3M USD | 71,86 USD | — | 0,00 USD | — |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | 474,6M USD | 6,03 USD | — | 31,2M USD | -182,5% |
| RLMD | RELMADA THERAPEUTICS, INC. | non valutata | 473,1M USD | 4,44 USD | — | — | — |
| CTMX | CytomX Therapeutics, Inc. | F- | 465,4M USD | 2,14 USD | — | 14M USD | -609,0% |
| ASMB | Assembly Biosciences, Inc. | B- | 454,9M USD | 22,34 USD | — | 72,3M USD | -15,4% |
| ARVN | ARVINAS, INC. | C- | 452,5M USD | 6,91 USD | — | 275,3M USD | -3,5% |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | D- | 448,8M USD | 8,74 USD | — | 52,7M USD | -45,4% |
| YDES | YD Bio Limited | D | 440,3M USD | 6,22 USD | — | 596,8K USD | -1392,6% |
| TECX | TECTONIC THERAPEUTIC, INC. | non valutata | 438,9M USD | 22,00 USD | — | — | — |
| KRSA | Korsana Biosciences, Inc. | F | 427,5M USD | 31,61 USD | — | 1,9M USD | -3098,7% |
| INDP | Indaptus Therapeutics, Inc. | non valutata | 426,4M USD | 3,20 USD | — | — | — |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | non valutata | 422,9M USD | 1,95 USD | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | 418,2M USD | 8,09 USD | 17,59 | 231,8M USD | 10,3% |
| IRD | Opus Genetics, Inc. | F- | 415,6M USD | 4,30 USD | — | 7,9M USD | -1726,7% |
| LYEL | Lyell Immunopharma, Inc. | F- | 414,5M USD | 16,86 USD | — | 15K USD | -1.701.066,7% |
| CRMD | CORMEDIX INC. | B+ | 413,9M USD | 5,31 USD | 2,59 | 462,2M USD | 13,8% |
| OCS | Oculis Holding AG | non valutata | 397,6M USD | 7,61 USD | — | — | — |
| SPRY | ARS Pharmaceuticals, Inc. | F- | 397,1M USD | 3,95 USD | — | 122,1M USD | -163,6% |
| KARD | Kardigan, Inc. | non valutata | 396,1M USD | 15,72 USD | — | — | — |
| RZLT | Rezolute, Inc. | non valutata | 395,6M USD | 4,09 USD | — | — | — |
| ALEC | Alector, Inc. | B+ | 388,6M USD | 2,61 USD | 7,46 | 173,5M USD | 23,9% |
| CCCC | C4 Therapeutics, Inc. | D- | 378,2M USD | 2,88 USD | — | 32,3M USD | -282,2% |
| ALT | ALTIMMUNE, INC. | D- | 375,4M USD | 1,93 USD | — | 41K USD | -254.522,0% |
| FENC | FENNEC PHARMACEUTICALS INC. | C- | 373,5M USD | 10,65 USD | — | 59,2M USD | -5,5% |
| EDIT | EDITAS MEDICINE, INC. | B- | 367,3M USD | 2,38 USD | — | 49,8M USD | -145,0% |
| PEPG | PEPGEN INC. | non valutata | 365M USD | 5,27 USD | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | non valutata | 360,2M USD | 6,65 USD | — | — | — |
| ANL | Adlai Nortye Ltd. | C | 347,1M USD | 10,86 USD | — | 5M USD | -710,6% |
| IMUX | Immunic, Inc. | non valutata | 346,9M USD | 8,16 USD | — | — | — |
| FTH | Faeth Therapeutics, Inc. | non valutata | 345M USD | 13,35 USD | — | — | — |
| PROK | ProKidney Corp. | F- | 340,2M USD | 1,13 USD | — | 775K USD | -13.326,7% |
| AVIR | Atea Pharmaceuticals, Inc. | non valutata | 338,1M USD | 4,21 USD | — | — | — |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | 337,7M USD | 11,60 USD | — | 65,3M USD | -96,9% |
| GALT | GALECTIN THERAPEUTICS INC. | non valutata | 332,3M USD | 3,30 USD | — | — | — |
| BNTC | BENITEC BIOPHARMA INC. | D | 329,6M USD | 9,45 USD | — | 0,00 USD | — |
| XFOR | X4 PHARMACEUTICALS, INC | D- | 328,8M USD | 3,22 USD | — | 17M USD | -474,7% |
| AUTL | AUTOLUS THERAPEUTICS PLC | C- | 327,6M USD | 1,23 USD | — | 137,4M USD | -186,4% |
| AGEN | AGENUS INC | D | 327,1M USD | 7,23 USD | 10,95 | 133,9M USD | 23,0% |
| OCGN | OCUGEN, INC. | F | 325,1M USD | 0,96 USD | — | 4,8M USD | -1367,6% |
| TTRX | Turn Therapeutics Inc. | non valutata | 324,7M USD | 10,62 USD | — | — | — |
| KYTX | Kyverna Therapeutics, Inc. | non valutata | 323,1M USD | 5,11 USD | — | — | — |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | 321,2M USD | 8,04 USD | — | 0,00 USD | — |
| SCTX | SCRIBE THERAPEUTICS INC. | non valutata | 319,3M USD | 16,86 USD | — | — | — |
| IPSC | Century Therapeutics, Inc. | C- | 317,8M USD | 1,75 USD | — | 109,2M USD | -90,5% |
| MPLT | MapLight Therapeutics, Inc. | non valutata | 317M USD | 7,47 USD | — | — | — |
| CABA | CABALETTA BIO, INC. | non valutata | 315M USD | 1,46 USD | — | — | — |
| EVMN | Evommune, Inc. | D- | 313,9M USD | 8,65 USD | — | 10M USD | -1130,7% |
| ALLO | Allogene Therapeutics, Inc. | C- | 313,1M USD | 0,90 USD | — | 6,9M USD | -2513,9% |
| VERU | VERU INC. | non valutata | 308,9M USD | 2,11 USD | — | — | — |
| VOGX | Vogenx, Inc. | non valutata | 308,5M USD | 20,77 USD | — | — | — |
| NAUT | NAUTILUS BIOTECHNOLOGY, INC. | non valutata | 306,3M USD | 2,41 USD | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | 302,5M USD | 3,79 USD | — | 22,4M USD | -269,7% |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | 286,1M USD | 3,75 USD | — | 0,00 USD | — |
| LRMR | LARIMAR THERAPEUTICS, INC. | non valutata | 284,6M USD | 2,74 USD | — | — | — |
| LCTX | Lineage Cell Therapeutics, Inc. | F | 284,5M USD | 1,13 USD | — | 10,8M USD | 16,2% |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | 280,7M USD | 12,87 USD | — | 0,00 USD | — |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | 279,3M USD | 3,10 USD | — | 0,00 USD | — |
| INO | INOVIO PHARMACEUTICALS, INC. | C- | 277,2M USD | 1,48 USD | — | 298,9K USD | -23.798,9% |
| QTTB | Q32 Bio Inc. | B | 275,3M USD | 9,20 USD | 2,65 | 53,7M USD | 60,0% |
| RCKT | Rocket Pharmaceuticals, Inc. | D | 271,1M USD | 2,47 USD | — | 0,00 USD | — |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | 268,3M USD | 9,31 USD | — | 30,5M USD | -285,9% |
| PLX | PROTALIX BIOTHERAPEUTICS, INC. | A+ | 264,3M USD | 3,14 USD | 12,54 | 84,7M USD | 24,3% |
| CAMP | CAMP4 Therapeutics Corporation | B- | 261,7M USD | 4,17 USD | — | 5,3M USD | -2276,3% |
| BCYC | Bicycle Therapeutics plc | C- | 258,2M USD | 3,69 USD | — | 83,5M USD | -169,8% |
| CUVL | CLINUVEL PHARMACEUTICALS LIMITED | C+ | 256,7M USD | 5,09 USD | 11,07 | 64,3M USD | 36,0% |
| DTIL | PRECISION BIOSCIENCES INC | D- | 255,3M USD | 9,14 USD | — | 45M USD | -85,6% |
| LXEO | Lexeo Therapeutics, Inc. | non valutata | 252,3M USD | 3,08 USD | — | — | — |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | 250,9M USD | 4,15 USD | — | 229,3M USD | -119,9% |
| CTNM | Contineum Therapeutics, Inc. | non valutata | 249M USD | 10,78 USD | — | — | — |
| IMRX | Immuneering Corporation | non valutata | 245,3M USD | 3,79 USD | — | — | — |
| IRLA | Quince Therapeutics, Inc. | non valutata | 242,4M USD | 39,53 USD | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | non valutata | 237,3M USD | 16,17 USD | — | — | — |
| ACIU | AC IMMUNE SA | D- | 229,9M USD | 2,26 USD | — | 4,5M USD | -1903,0% |
| IKT | INHIBIKASE THERAPEUTICS, INC. | F | 227,9M USD | 1,63 USD | — | 0,00 USD | — |
| ELDN | Eledon Pharmaceuticals, Inc. | non valutata | 217M USD | 2,67 USD | — | — | — |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | 213,8M USD | 5,46 USD | — | 4M USD | -4058,0% |
| PALI | PALISADE BIO, INC. | F- | 209,8M USD | 1,17 USD | — | 500K USD | -8739,2% |
| RNAC | Cartesian Therapeutics, Inc. | F | 208M USD | 6,82 USD | — | 1M USD | -12.435,2% |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | non valutata | 205,8M USD | 2,57 USD | — | — | — |
| HELP | CYBIN INC. | non valutata | 202,8M USD | 9,39 USD | — | — | — |
| ARTV | Artiva Biotherapeutics, Inc. | F- | 201,2M USD | 4,07 USD | — | 0,00 USD | — |
| ALPS | ALPS GROUP INC | non valutata | 199,7M USD | 1,20 USD | — | — | — |
| OVID | Ovid Therapeutics Inc. | D- | 197,7M USD | 2,79 USD | — | 1,5M USD | -2971,3% |
| KRRO | Korro Bio, Inc. | D- | 197,6M USD | 14,40 USD | — | 1,3M USD | -8214,5% |
| CGEN | COMPUGEN LTD | B+ | 196,7M USD | 2,08 USD | 5,47 | 75,9M USD | 47,9% |
| LIMN | LIMINATUS PHARMA, INC. | non valutata | 195,8M USD | 2,92 USD | — | — | — |
| PYXS | Pyxis Oncology, Inc. | D- | 195M USD | 1,63 USD | — | 13,9M USD | -625,7% |
| FATE | FATE THERAPEUTICS INC | F- | 194,5M USD | 1,60 USD | — | 4,8M USD | -2619,6% |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | 191,2M USD | 3,24 USD | — | 0,00 USD | — |
| ACOG | Alpha Cognition Inc. | D- | 189,8M USD | 8,72 USD | — | 15,3M USD | -153,6% |
| KROS | KEROS THERAPEUTICS, INC. | F- | 187M USD | 9,53 USD | — | 40,8M USD | -151,4% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | 185,7M USD | 1,89 USD | — | 0,00 USD | — |
| MDWD | MEDIWOUND LTD. | F- | 177,5M USD | 13,83 USD | — | 11,9M USD | -170,1% |
| GTBP | GT Biopharma, Inc. | non valutata | 176,8M USD | 3,92 USD | 10,59 | — | — |
| IVVD | INVIVYD, INC. | D- | 176,2M USD | 0,60 USD | — | 58,4M USD | -183,9% |
| SLGL | Sol-Gel Technologies Ltd. | D | 176,1M USD | 63,20 USD | — | 1,8M USD | -341,3% |
| CURX | Curanex Pharmaceuticals Inc | non valutata | 175,6M USD | 5,60 USD | — | — | — |
| UPB | UPSTREAM BIO, INC. | F- | 174,8M USD | 3,19 USD | — | 2,9M USD | -5712,3% |
| RNA | Atrium Therapeutics, Inc. | non valutata | 171,7M USD | 7,96 USD | — | — | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | 171,6M USD | 4,13 USD | — | 2M USD | 8743,5% |
| STRO | SUTRO BIOPHARMA, INC. | D | 169,9M USD | 10,25 USD | — | 45,1M USD | -344,2% |
| ANTX | AN2 Therapeutics, Inc. | non valutata | 169M USD | 4,46 USD | — | — | — |
| SION | SIONNA THERAPEUTICS, INC. | non valutata | 167,1M USD | 3,70 USD | — | — | — |
| HUMA | Humacyte, Inc. | C- | 165M USD | 0,59 USD | — | 2,4M USD | -3955,1% |
| TARA | Protara Therapeutics, Inc. | non valutata | 161,3M USD | 2,62 USD | — | — | — |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | non valutata | 160,6M USD | 23,35 USD | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | 160,1M USD | 8,22 USD | — | 0,00 USD | — |
| ALXO | ALX ONCOLOGY HOLDINGS INC | non valutata | 154,2M USD | 1,12 USD | — | — | — |
| CMPX | COMPASS THERAPEUTICS, INC. | F | 149,5M USD | 0,83 USD | — | 0,00 USD | — |
| IPHA | Innate Pharma SA | F- | 149M USD | 1,59 USD | — | 10,1M USD | -546,1% |
| MGNX | MACROGENICS, INC. | D- | 148,6M USD | 2,33 USD | — | 154,9M USD | -33,2% |
| ARMP | ARMATA PHARMACEUTICALS, INC. | non valutata | 141,7M USD | 3,81 USD | — | — | — |
| ZURA | Zura Bio Limited | non valutata | 137,7M USD | 1,43 USD | — | — | — |
| CUE | Cue Biopharma, Inc. | D- | 137,4M USD | 18,92 USD | — | 37,7M USD | -435,8% |
| OKUR | ONKURE THERAPEUTICS, INC. | non valutata | 135,5M USD | 3,35 USD | — | — | — |
| CLLS | Cellectis S.A. | F- | 135,4M USD | 1,35 USD | — | 56,6M USD | -115,4% |
| SPRB | Spruce Biosciences, Inc. | F | 133,8M USD | 46,54 USD | — | 0,00 USD | — |
| PRQR | ProQR Therapeutics N.V. | C- | 132,8M USD | 1,26 USD | — | 20,5M USD | -229,7% |
| ABEO | ABEONA THERAPEUTICS INC. | C- | 130,9M USD | 2,29 USD | — | 39M USD | -160,3% |
| MENS | Jyong Biotech Ltd. | non valutata | 130,8M USD | 1,72 USD | — | — | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | 129,8M USD | 4,50 USD | — | 40K USD | -107.587,6% |
| MOLN | MOLECULAR PARTNERS AG | F | 129,8M USD | 3,22 USD | — | 0,00 USD | — |
| LENZ | LENZ THERAPEUTICS, INC. | F- | 128,8M USD | 4,10 USD | — | 12,4M USD | -1135,0% |
| NERV | Minerva Neurosciences, Inc. | non valutata | 127,1M USD | 2,55 USD | — | — | — |
| ADAG | Adagene Inc. | C- | 126,2M USD | 2,13 USD | — | 7,7M USD | -229,6% |
| FHTX | Foghorn Therapeutics Inc. | B | 125,3M USD | 2,09 USD | 29,86 | 112,1M USD | 8,4% |
| IBIO | iBio, Inc. | C- | 124,4M USD | 0,82 USD | — | 1,1M USD | -3244,2% |
| ENGN | enGene Therapeutics Inc. | non valutata | 121,3M USD | 1,81 USD | — | — | — |
| PYPD | PolyPid Ltd | non valutata | 119,9M USD | 6,59 USD | — | — | — |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | 117,4M USD | 0,48 USD | — | -1,2M USD | 5253,5% |
| VYGR | Voyager Therapeutics, Inc. | F- | 109,5M USD | 1,76 USD | — | 25,1M USD | -416,3% |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | 108,3M USD | 4,37 USD | — | 194K USD | -3985,6% |
| MSLE | Satellos Bioscience Inc. | non valutata | 107,1M USD | 6,93 USD | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | non valutata | 106,7M USD | 1,34 USD | — | — | — |
| CDXS | Codexis, Inc. | B- | 106,7M USD | 0,97 USD | — | 88,3M USD | -21,8% |
| NKTX | Nkarta, Inc. | D | 105,4M USD | 1,47 USD | — | 0,00 USD | — |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | non valutata | 105M USD | 3,77 USD | — | — | — |
| VANI | Vivani Medical, Inc. | F | 100,6M USD | 1,12 USD | — | 0,00 USD | — |
| NBP | NovaBridge Biosciences | non valutata | 99,4M USD | 0,86 USD | — | — | — |
| AVXL | ANAVEX LIFE SCIENCES CORP. | non valutata | 97,3M USD | 1,05 USD | — | — | — |
| ANIX | ANIXA BIOSCIENCES, INC. | non valutata | 96,6M USD | 2,78 USD | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | 96,2M USD | 1,51 USD | — | 0,00 USD | — |
| PMVP | PMV PHARMACEUTICALS, INC. | non valutata | 94,8M USD | 1,26 USD | — | — | — |
| PLYX | Polaryx Therapeutics, Inc. | non valutata | 94,7M USD | 1,90 USD | — | — | — |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | F | 91,9M USD | 1,60 USD | — | 0,00 USD | — |
| ICCC | ImmuCell Corporation | B | 91,7M USD | 10,10 USD | 144,29 | 30,7M USD | 2,6% |
| CHRS | Coherus Oncology, Inc. | C | 90M USD | 0,58 USD | — | 53,6M USD | -253,4% |
| LONA | LeonaBio, Inc. | non valutata | 89,4M USD | 3,77 USD | — | — | — |
| EQ | EQUILLIUM, INC. | D- | 89,4M USD | 1,41 USD | — | 41,1M USD | -43,8% |
| SEER | SEER, INC. | F- | 89,3M USD | 1,60 USD | — | 14,1M USD | -450,9% |
| NMRA | NEUMORA THERAPEUTICS, INC. | non valutata | 88,3M USD | 0,47 USD | — | — | — |
| CBUS | Cibus, Inc. | C- | 87,9M USD | 1,15 USD | — | 4,5M USD | -2131,4% |
| NRXS | NEURAXIS, INC. | D- | 86,9M USD | 6,12 USD | — | 6,5M USD | -185,2% |
| GNLX | GENELUX CORPORATION | F- | 86,4M USD | 1,91 USD | — | 8K USD | -444.950,0% |
| RLYB | RALLYBIO CORPORATION | A | 85,1M USD | 15,81 USD | — | 434K USD | 6177,4% |
| IFRX | InflaRx N.V. | F- | 84,9M USD | 1,18 USD | — | 32,8K USD | -155.582,1% |
| TNYA | TENAYA THERAPEUTICS, INC. | non valutata | 84,5M USD | 0,37 USD | — | — | — |
| MIST | Milestone Pharmaceuticals Inc. | non valutata | 84,4M USD | 0,68 USD | — | — | — |
| ATRA | Atara Biotherapeutics, Inc. | F | 84,2M USD | 8,26 USD | — | 4M USD | -368,6% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | non valutata | 82,6M USD | 4,01 USD | — | — | — |
| JAGX | Jaguar Health, Inc. | C | 82,4M USD | 0,48 USD | — | 27,8M USD | -132,2% |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | 78,9M USD | 0,57 USD | — | 6,6M USD | -493,0% |
| TENX | TENAX THERAPEUTICS, INC. | F | 77,2M USD | 1,70 USD | — | 0,00 USD | — |
| TLSA | Tiziana Life Sciences Ltd | non valutata | 76M USD | 0,63 USD | — | — | — |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | 74,6M USD | 3,84 USD | — | 43M USD | -420,4% |
| COYA | Coya Therapeutics, Inc. | F- | 74,6M USD | 3,18 USD | — | 4,7M USD | -643,5% |
| OKYO | OKYO Pharma Limited | non valutata | 73,7M USD | 1,41 USD | — | — | — |
| NTRB | NUTRIBAND INC. | F- | 72,3M USD | 5,95 USD | — | 1,6M USD | -430,4% |
| GOSS | GOSSAMER BIO, INC. | B | 71,4M USD | 11,68 USD | — | 78,4M USD | -159,5% |
| MNOV | MEDICINOVA, INC. | C- | 68,9M USD | 1,40 USD | — | 920,5K USD | -1168,2% |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | D- | 68M USD | 0,36 USD | — | 148,2M USD | -14,5% |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | 67,9M USD | 4,88 USD | — | 60,7M USD | -1,8% |
| ACRV | Acrivon Therapeutics, Inc. | non valutata | 67,7M USD | 1,58 USD | — | — | — |
| CING | Cingulate Inc. | non valutata | 67,6M USD | 4,65 USD | — | — | — |
| CNXU | CONEXEU SCIENCES INC. | non valutata | 67,4M USD | 2,39 USD | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | D- | 66,8M USD | 3,89 USD | — | 22,9M USD | -189,2% |
| CGTX | Cognition Therapeutics, Inc. | non valutata | 64,3M USD | 0,68 USD | — | — | — |
| MAIA | MAIA BIOTECHNOLOGY, INC. | non valutata | 64,2M USD | 1,04 USD | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | 63,9M USD | 2,01 USD | — | 68,5M USD | 163,3% |
| XLO | Xilio Therapeutics, Inc. | D- | 62,5M USD | 8,85 USD | — | 55M USD | -20,9% |
| CLNN | Clene Inc. | C | 60,4M USD | 4,20 USD | — | 238K USD | -11.271,4% |
| SPRO | Spero Therapeutics, Inc. | C | 60M USD | 1,03 USD | 7,36 | 47M USD | 15,7% |
| XBIT | XBiotech Inc. | non valutata | 59,8M USD | 1,96 USD | — | — | — |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | 59,6M USD | 0,77 USD | — | 559K USD | -6735,2% |
| RNXT | RENOVORX, INC. | D- | 59,3M USD | 1,23 USD | — | 2,8M USD | -469,0% |
| BOLD | BOUNDLESS BIO, INC. | non valutata | 57,6M USD | 2,44 USD | — | — | — |
| PDSB | PDS Biotechnology Corporation | non valutata | 56,5M USD | 1,01 USD | — | — | — |
| BCAB | BIOATLA, INC. | non valutata | 56,1M USD | 1,74 USD | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | non valutata | 56M USD | 1,72 USD | — | — | — |
| INKT | MiNK Therapeutics, Inc. | non valutata | 55,1M USD | 10,79 USD | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | 53,3M USD | 13,20 USD | 1,57 | 0,00 USD | — |
| RNTX | Rein Therapeutics, Inc. | F | 52,8M USD | 0,61 USD | — | 0,00 USD | — |
| ONCY | ONCOLYTICS BIOTECH INC. | non valutata | 52,6M USD | 0,41 USD | — | — | — |
| AZR | AZORA THERAPEUTICS, INC. | non valutata | 52,4M USD | 3,67 USD | — | — | — |
| ATNM | Actinium Pharmaceuticals, Inc. | D+ | 50,9M USD | 1,62 USD | 4,50 | 90K USD | 12.564,4% |
| CLGN | CollPlant Biotechnologies Ltd | D- | 50,7M USD | 3,96 USD | — | 318K USD | -4130,2% |
| MREO | MEREO BIOPHARMA GROUP PLC | C | 48,8M USD | 0,31 USD | — | 500K USD | -5387,6% |
| GANX | GAIN THERAPEUTICS, INC | non valutata | 48,8M USD | 1,10 USD | — | — | — |
| PLRX | PLIANT THERAPEUTICS, INC. | D | 48,3M USD | 0,78 USD | — | 0,00 USD | — |
| HYFT | MindWalk Holdings Corp. | C- | 47,9M USD | 1,03 USD | — | 20,1M USD | -43,6% |
| HOWL | WEREWOLF THERAPEUTICS, INC. | non valutata | 47,9M USD | 0,98 USD | — | — | — |
| IMA | ImageneBio, Inc. | C- | 47,8M USD | 3,84 USD | — | 800K USD | -5415,6% |
| DWTX | Dogwood Therapeutics, Inc. | non valutata | 46,3M USD | 1,21 USD | — | — | — |
| ELTX | Elicio Therapeutics, Inc. | non valutata | 45,7M USD | 1,62 USD | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | non valutata | 45,3M USD | 1,91 USD | — | — | — |
| BMEA | Biomea Fusion, Inc. | non valutata | 44,4M USD | 0,61 USD | — | — | — |
| BLSM | BlossomHill Therapeutics, Inc. | non valutata | 43,7M USD | 16,10 USD | — | — | — |
| TELO | Telomir Pharmaceuticals, Inc. | non valutata | 43,7M USD | 0,59 USD | — | — | — |
| CNTB | Connect Biopharma Holdings Limited | C- | 43M USD | 0,68 USD | — | 3M USD | -2336,3% |
| TIL | Instil Bio, Inc. | C- | 42,9M USD | 6,32 USD | — | 9M USD | -337,7% |
| HYPD | HYPERION DEFI, INC. | D+ | 42,3M USD | 2,73 USD | — | 1,4M USD | 474,9% |
| CRBU | Caribou Biosciences, Inc. | F- | 42,1M USD | 0,39 USD | — | 9,4M USD | -1085,0% |
| SER | Serina Therapeutics, Inc. | D | 40,9M USD | 1,54 USD | — | 260K USD | -9421,5% |
| OSTX | OS THERAPIES INCORPORATED | non valutata | 40,9M USD | 0,89 USD | — | — | — |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | 40M USD | 1,57 USD | — | 357,9K USD | -3089,6% |
| GRCE | Grace Therapeutics, Inc. | non valutata | 39,5M USD | 1,88 USD | — | — | — |
| GRDX | GridAI Technologies Corp. | F- | 39,4M USD | 5,53 USD | — | 36,3K USD | -56.864,0% |
| ALDX | ALDEYRA THERAPEUTICS, INC. | non valutata | 39,2M USD | 0,65 USD | — | — | — |
| EXOZ | EXOZYMES INC. | non valutata | 38,6M USD | 4,16 USD | — | — | — |
| IBO | Impact BioMedical, INC. | A | 37,2M USD | 4,30 USD | — | 38K USD | 4247,4% |
| TVGN | Tevogen Inc. | non valutata | 37M USD | 5,68 USD | — | — | — |
| ANVS | Annovis Bio, Inc. | F | 36M USD | 0,84 USD | — | 0,00 USD | — |
| NNVC | NANOVIRICIDES, INC. | F | 35,7M USD | 1,40 USD | — | 0,00 USD | — |
| PTHS | Pelthos Therapeutics Inc. | C- | 35,7M USD | 9,33 USD | — | 58,4M USD | -133,6% |
| AARD | AARDVARK THERAPEUTICS, INC. | F | 34,8M USD | 1,59 USD | — | 0,00 USD | — |
| INMB | INMUNE BIO INC. | D- | 34,1M USD | 1,10 USD | — | 50K USD | -33.332,0% |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | non valutata | 33,9M USD | 0,78 USD | — | — | — |
| PMN | PROMIS NEUROSCIENCES INC. | non valutata | 33,9M USD | 3,78 USD | — | — | — |
| EYPT | EyePoint, Inc. | F- | 31,5M USD | 0,37 USD | — | 2,6M USD | -13.281,2% |
| BCTX | BRIACELL THERAPEUTICS CORP. | non valutata | 31,1M USD | 3,57 USD | — | — | — |
| SKYE | Skye Bioscience, Inc. | non valutata | 30,3M USD | 0,86 USD | — | — | — |
| LITS | Lite Strategy, Inc. | D | 29,2M USD | 0,98 USD | — | 0,00 USD | — |
| NXTC | NextCure, Inc. | non valutata | 28,8M USD | 6,29 USD | — | — | — |
| MGX | Metagenomi Therapeutics, Inc. | F- | 28,3M USD | 0,75 USD | — | 22,3M USD | -421,8% |
| ACET | Adicet Bio, Inc. | non valutata | 27,9M USD | 2,98 USD | — | — | — |
| CNSP | CNS Pharmaceuticals, Inc. | non valutata | 27,8M USD | 4,07 USD | — | — | — |
| ALGS | Aligos Therapeutics, Inc. | F- | 27,5M USD | 2,20 USD | — | 5,8M USD | -1137,2% |
| ABVC | ABVC BioPharma, Inc. | D- | 26,9M USD | 1,00 USD | — | 296K USD | -1322,6% |
| CRVO | CervoMed Inc. | F- | 26,8M USD | 1,77 USD | — | 8,7K USD | -326.822,5% |
| BYSI | BeyondSpring Inc. | D | 26,4M USD | 0,64 USD | — | 0,00 USD | — |
| IMMP | Immutep Limited | D- | 26,4M USD | 3,58 USD | — | 7,3M USD | -594,6% |
| BSEM | BioStem Technologies, Inc. | F- | 26,2M USD | 1,47 USD | — | 34,6M USD | -81,8% |
| ATHE | ALTERITY THERAPEUTICS LTD | non valutata | 24,6M USD | 2,31 USD | — | — | — |
| ENLV | Enlivex Ltd. | non valutata | 24,4M USD | 1,26 USD | 0,01 | — | — |
| FLNA | Filana Therapeutics, Inc. | non valutata | 24,2M USD | 0,48 USD | — | — | — |
| EVAX | Evaxion A/S | B- | 24,2M USD | 2,90 USD | — | 7,5M USD | -102,4% |
| CELU | Celularity Inc. | D | 24,1M USD | 0,74 USD | — | 18,7M USD | -245,7% |
| APRE | Aprea Therapeutics, Inc. | non valutata | 23,9M USD | 0,44 USD | — | — | — |
| CVM | CEL-SCI CORPORATION | non valutata | 23,1M USD | 1,32 USD | — | — | — |
| IGC | IGC PHARMA, INC. | C- | 22,8M USD | 0,20 USD | — | 1,3M USD | -560,3% |
| EDSA | EDESA BIOTECH, INC. | non valutata | 22,1M USD | 2,29 USD | — | — | — |
| NRXP | NRX Pharmaceuticals, Inc. | B | 21,5M USD | 2,43 USD | — | 3,4M USD | -691,8% |
| ICU | SeaStar Medical Holding Corporation | D- | 21,4M USD | 1,89 USD | — | 2,2M USD | -678,2% |
| ATOS | ATOSSA THERAPEUTICS, INC. | non valutata | 20,3M USD | 2,03 USD | — | — | — |
| APLM | Apollomics Inc. | B | 20,1M USD | 18,25 USD | — | 8,5M USD | -128,7% |
| COCP | COCRYSTAL PHARMA, INC. | non valutata | 19,9M USD | 1,04 USD | — | — | — |
| CNTX | CONTEXT THERAPEUTICS INC. | non valutata | 19,6M USD | 0,21 USD | — | — | — |
| KTTA | PASITHEA THERAPEUTICS CORP. | non valutata | 18,4M USD | 0,55 USD | — | — | — |
| LPCN | LIPOCINE INC. | D- | 17,7M USD | 1,60 USD | — | 3,7M USD | -249,2% |
| TVRD | TVARDI THERAPEUTICS, INC. | C- | 17,5M USD | 1,31 USD | — | 7,6M USD | -344,2% |
| ATYR | ATYR PHARMA, INC. | F- | 17,4M USD | 6,81 USD | — | 190K USD | -28.065,3% |
| ABOS | Acumen Pharmaceuticals, Inc. | non valutata | 16,9M USD | 0,23 USD | — | — | — |
| GOVX | GEOVAX LABS, INC. | F | 15,9M USD | 2,16 USD | — | 0,00 USD | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | 15,8M USD | 0,95 USD | — | 3,9M USD | -220,5% |
| YARW | YARROW BIOSCIENCE, INC. | D- | 15,5M USD | 18,10 USD | — | 482K USD | -3881,5% |
| MCRB | Seres Therapeutics, Inc. | D- | 15,4M USD | 1,51 USD | — | 2,1M USD | -2209,6% |
| ALLR | Allarity Therapeutics, Inc. | B- | 15,2M USD | 0,95 USD | — | 345K USD | -3575,1% |
| KYNB | KYNTRA BIO, INC. | F | 15,1M USD | 3,74 USD | — | 4,6M USD | 3967,8% |
| ONCO | Onconetix, Inc. | F- | 14,8M USD | 3,76 USD | — | 645,8K USD | -1578,8% |
| PLUR | Pluri Inc. | F | 14,8M USD | 1,20 USD | — | 1M USD | -2344,6% |
| BCDA | BioCardia, Inc. | F | 13,9M USD | 0,92 USD | — | 0,00 USD | — |
| DYAI | DYADIC INTERNATIONAL INC | F- | 13,8M USD | 0,38 USD | — | 3,8M USD | -200,5% |
| BIVI | BIOVIE INC. | non valutata | 13,5M USD | 1,26 USD | — | — | — |
| CTXR | Citius Pharmaceuticals, Inc. | non valutata | 13,2M USD | 0,48 USD | — | — | — |
| NCEL | NewcelX Ltd. | non valutata | 13,1M USD | 2,74 USD | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | 12,6M USD | 0,19 USD | — | 7,1M USD | -1618,4% |
| ELAB | PMGC HOLDINGS INC. | D- | 12,5M USD | 1,54 USD | — | 2,6M USD | -523,0% |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | 12,3M USD | 6,90 USD | — | 13,2M USD | -63,6% |
| NIKI | Niki BioSolutions, Inc. | non valutata | 12,3M USD | 1,67 USD | — | — | — |
| PASG | Passage BIO, Inc. | non valutata | 12,2M USD | 3,81 USD | — | — | — |
| KAPA | KAIROS PHARMA, LTD. | non valutata | 12,1M USD | 0,51 USD | — | — | — |
| KZIA | Kazia Therapeutics Limited. | F | 12,1M USD | 7,46 USD | 6,57 | 29,5K USD | -54.287,3% |
| BOLT | Bolt Biotherapeutics, Inc. | F- | 12M USD | 6,25 USD | — | 4,7M USD | -553,6% |
| CLRB | Cellectar Biosciences, Inc. | non valutata | 11,8M USD | 1,18 USD | — | — | — |
| AZTR | Azitra, Inc. | F- | 11,7M USD | 0,61 USD | — | 0,00 USD | — |
| GUTS | Fractyl Health, Inc. | F- | 11,6M USD | 0,87 USD | — | 0,00 USD | — |
| INTS | INTENSITY THERAPEUTICS, INC. | non valutata | 11,2M USD | 3,38 USD | — | — | — |
| HIND | VYOME HOLDINGS, INC. | F- | 10,8M USD | 1,54 USD | — | 129,7K USD | -8716,8% |
| LSTA | Lisata Therapeutics, Inc. | D- | 10,7M USD | 1,19 USD | — | 100K USD | -14.621,0% |
| DARE | Dare Bioscience, Inc. | C- | 10,7M USD | 0,70 USD | — | 1,4M USD | -804,4% |
| ARTL | ARTELO BIOSCIENCES, INC. | non valutata | 10M USD | 2,18 USD | — | — | — |
| GDTC | CytoMed Therapeutics Limited | D- | 10M USD | 0,85 USD | — | 253,7K USD | -1227,1% |
| CMMB | SNOWDRIFT PARENT CORPORATION | non valutata | 9,9M USD | 1,38 USD | — | — | — |
| INAB | IN8BIO, INC. | non valutata | 9,8M USD | 0,91 USD | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | 9,7M USD | 0,82 USD | — | 3,6M USD | -1055,3% |
| MTVA | METAVIA INC. | non valutata | 9,5M USD | 1,44 USD | — | — | — |
| CALC | CalciMedica, Inc. | non valutata | 8,8M USD | 1,27 USD | — | — | — |
| AEON | AEON Biopharma, Inc. | non valutata | 8,6M USD | 0,17 USD | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | 8,3M USD | 0,19 USD | — | 2,5M USD | -2702,6% |
| SNGX | SOLIGENIX, INC. | non valutata | 7,5M USD | 0,32 USD | — | — | — |
| TOVX | Theriva Biologics, Inc. | non valutata | 7,4M USD | 0,16 USD | — | — | — |
| ACTU | ACTUATE THERAPEUTICS, INC. | non valutata | 7,3M USD | 0,31 USD | — | — | — |
| IMRN | IMMURON LIMITED | D- | 7,2M USD | 0,89 USD | — | 5,1M USD | -71,6% |
| ENVB | ENVERIC BIOSCIENCES, INC. | non valutata | 6,8M USD | 1,52 USD | — | — | — |
| ENSC | Ensysce Biosciences, Inc. | D- | 6,8M USD | 0,35 USD | — | 4,5M USD | -280,5% |
| XCUR | EXICURE, INC. | F | 6,8M USD | 1,04 USD | — | 0,00 USD | — |
| ALZN | ALZAMEND NEURO, INC. | non valutata | 6,4M USD | 1,34 USD | — | — | — |
| BLRX | BioLineRx Ltd | C- | 6,4M USD | 1,48 USD | — | 1,4M USD | -145,5% |
| FBLG | FibroBiologics, Inc. | non valutata | 6,2M USD | 0,94 USD | — | — | — |
| LTRN | LANTERN PHARMA INC. | non valutata | 6,2M USD | 0,49 USD | — | — | — |
| CNSY | CERENOME, INC. | F- | 6,1M USD | 0,80 USD | — | 4,2M USD | -620,7% |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | 5,9M USD | 1,33 USD | — | 0,00 USD | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | B- | 5,8M USD | 1,96 USD | — | 15,2K USD | -42.721,9% |
| TPST | Tempest Therapeutics, Inc. | non valutata | 5,8M USD | 0,39 USD | — | — | — |
| CMND | Clearmind Medicine Inc. | non valutata | 5,8M USD | 4,95 USD | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | non valutata | 5,6M USD | 0,88 USD | — | — | — |
| ACXP | Acurx Pharmaceuticals, Inc. | non valutata | 5,5M USD | 1,04 USD | — | — | — |
| PCSA | Processa Pharmaceuticals, Inc. | non valutata | 5,2M USD | 1,87 USD | — | — | — |
| PULM | Pulmatrix, Inc. | C- | 5,1M USD | 1,39 USD | — | 7,8M USD | -51,4% |
| CVKD | Cadrenal Therapeutics, Inc. | non valutata | 4,9M USD | 1,37 USD | — | — | — |
| SNTI | Senti Biosciences Holdings, Inc. | F- | 4,9M USD | 0,16 USD | — | 55K USD | -90.116,4% |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | D- | 4,7M USD | 0,62 USD | — | 3K USD | -249.160,1% |
| IMNN | Imunon, Inc. | non valutata | 4,7M USD | 0,72 USD | — | — | — |
| PMCB | PHARMACYTE BIOTECH, INC. | D | 4,6M USD | 0,43 USD | — | 0,00 USD | — |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | 4,5M USD | 1,91 USD | — | 451K USD | -1545,2% |
| AIM | AIM ImmunoTech Inc. | D | 4,5M USD | 0,15 USD | — | 95K USD | -15.021,1% |
| XBIO | XENETIC BIOSCIENCES, INC. | D- | 4,2M USD | 1,80 USD | — | 3,3M USD | -75,9% |
| OSRH | OSR HEALTH, INC. | D- | 4,1M USD | 0,12 USD | — | 1,8M USD | -824,4% |
| TCRT | Alaunos Therapeutics, Inc. | D- | 4,1M USD | 1,61 USD | — | 3K USD | -133.666,7% |
| PHIO | Phio Pharmaceuticals Corp | non valutata | 4M USD | 0,84 USD | — | — | — |
| GRI | GRI BIO, INC. | non valutata | 4M USD | 1,84 USD | — | — | — |
| TRAW | Traws Pharma, Inc. | D- | 3,8M USD | 0,24 USD | — | 2,8M USD | -773,0% |
| AGMB | AgomAb Therapeutics NV | non valutata | 3,8M USD | 6,93 USD | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | non valutata | 3,5M USD | 0,71 USD | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | 3,5M USD | 2,81 USD | — | 36,4K USD | -22.448,4% |
| MBIO | MUSTANG BIO, INC. | non valutata | 3,4M USD | 0,45 USD | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | non valutata | 3,3M USD | 1,95 USD | — | — | — |
| EVGN | EVOGENE LTD. | F | 3,2M USD | 0,37 USD | — | 1,3M USD | -551,3% |
| SILO | SILO PHARMA, INC. | F- | 2,9M USD | 1,83 USD | — | 54,1K USD | -8269,5% |
| REVB | REVELATION BIOSCIENCES, INC. | non valutata | 2,9M USD | 4,23 USD | — | — | — |
| VRAX | Virax Biolabs Group Ltd | C- | 2,2M USD | 0,60 USD | — | 6,3K USD | -95.739,2% |
| SLXN | Silexion Therapeutics Corp | non valutata | 2,2M USD | 3,23 USD | — | — | — |
| QNTM | Quantum BioPharma Ltd. | non valutata | 2,2M USD | 1,95 USD | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | non valutata | 2M USD | 1,74 USD | — | — | — |
| GNPX | Genprex, Inc. | D | 1,8M USD | 2,25 USD | — | 0,00 USD | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | 1,8M USD | 0,52 USD | — | 1,1M USD | -729,9% |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | 1,8M USD | 0,51 USD | — | 3,1M USD | -270,9% |
| CLDI | Calidi Biotherapeutics, Inc. | non valutata | 1,7M USD | 0,68 USD | — | — | — |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | 1,7M USD | 2,21 USD | — | 21,8K USD | -42.206,9% |
| PBM | PSYENCE BIOMEDICAL LTD | non valutata | 1,7M USD | 3,03 USD | — | — | — |
| HCWB | HCW Biologics Inc. | B- | 1,7M USD | 0,91 USD | — | 6,7M USD | -83,8% |
| OGEN | ORAGENICS, INC. | non valutata | 1,6M USD | 0,36 USD | — | — | — |
| APVO | Aptevo Therapeutics Inc. | non valutata | 1,4M USD | 0,76 USD | — | — | — |
| BDRX | Biodexa Pharmaceuticals PLC | non valutata | 1,3M USD | 2,44 USD | — | — | — |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | non valutata | 1,3M USD | 1,38 USD | — | — | — |
| CANF | Can-Fite BioPharma Ltd. | F- | 1,3M USD | 1,57 USD | — | 405K USD | -2426,7% |
| CRIS | CURIS, INC. | F- | 1,2M USD | 0,60 USD | — | 4,3M USD | -490,3% |
| BBLG | Bone Biologics Corporation | non valutata | 1,2M USD | 0,36 USD | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | non valutata | 903,6K USD | 0,38 USD | — | — | — |
| VIVS | VivoSim Labs, Inc. | F | 797,4K USD | 0,15 USD | — | 112K USD | -11.016,1% |
| HLSQ | BiomX Inc. | non valutata | 739,4K USD | 0,07 USD | — | — | — |
| DCOY | Decoy Therapeutics Inc. | non valutata | 710,9K USD | 1,09 USD | — | — | — |
| QNRX | Quoin Pharmaceuticals, Ltd. | non valutata | 667,8K USD | 3,80 USD | — | — | — |
| EDVA | Endovia Health Sciences, Inc. | D | 548,9K USD | 0,18 USD | — | 32,1K USD | -53.856,5% |
| PLRZ | Polyrizon Ltd. | non valutata | 503,9K USD | 11,11 USD | 2,27 | — | — |
| LGVN | LONGEVERON INC. | F- | 449,8K USD | 3,25 USD | — | 1,2M USD | -1921,7% |
| VBIO | Valion Bio, Inc. | F- | 435,4K USD | 0,49 USD | — | 482K USD | -3890,0% |
| CDT | CDT EQUITY INC. | non valutata | 402,1K USD | 0,51 USD | — | — | — |
| SRZN | Surrozen, Inc./DE | D | 374,6K USD | 31,82 USD | — | 10,5M USD | -3706,4% |
| SPRC | SCISPARC LTD. | F- | 144,5K USD | 0,40 USD | — | 679K USD | -1793,7% |
| NEUP | Neuphoria Therapeutics Inc. | F- | 81,2K USD | 2,70 USD | — | 1,2M USD | -1145,7% |
| KALA | KALA BIO, INC. | F | 12,7K USD | 0,17 USD | — | 0,00 USD | — |
| KPTI | Karyopharm Therapeutics Inc. | C | 503,52 USD | 0,02 USD | — | 146,6M USD | -153,3% |
| PPBT | PURPLE BIOTECH LTD. | non valutata | 331,24 USD | 1,38 USD | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | non valutata | — | 13,25 USD | — | — | — |
| APGE | Apogee Therapeutics, Inc. | non valutata | — | 135,07 USD | — | — | — |
| ATAI | AtaiBeckley Inc. | non valutata | — | 7,35 USD | — | 4,1M USD | -16.142,0% |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | 0,74 USD | — | 0,00 USD | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | 84,95 USD | — | 42,2M USD | -1189,9% |
| ETRA | Electra Therapeutics, Inc. | non valutata | — | 9,42 USD | — | — | — |
| FBRX | FORTE BIOSCIENCES, INC. | non valutata | — | 76,99 USD | — | — | — |
| LNAI | LUNAI BIOWORKS INC. | B | — | 0,16 USD | — | 52K USD | -6852,0% |
| MLEC | MOOLEC SCIENCE SA | B | — | 0,85 USD | — | 333,6M USD | -52,9% |
| SLBT | SL Science Holding Ltd | non valutata | — | 0,68 USD | — | — | — |
| TBPH | Theravance Biopharma, Inc. | C | — | 17,03 USD | — | 104,3M USD | 51,6% |
| VCRE | Vicore Pharma Holding AB | non valutata | — | 11,03 USD | — | — | — |
| VRXA | Veraxa Biotech Holding AG | non valutata | — | 1,28 USD | — | — | — |
| VTVT | vTv Therapeutics Inc. | C- | — | 21,55 USD | — | 36,8M USD | -20,8% |
Fondamentali dai documenti depositati alla SEC, prezzi dall’ultimo passaggio dei dati di mercato. Ordina per qualsiasi colonna; le aziende senza cifra vanno in fondo in entrambi i versi.
Ordinato per capitalizzazione, dalla più grande; clicca una colonna per riordinare. Le aziende senza cifra vanno in fondo in entrambi i versi, perché un P/U mancante significa perdita e non convenienza. Nulla di tutto questo è una raccomandazione.